GL1X · GenesisL1 explorer

MolNFT v1 · #96923 · protein

Crystal structure of human Fab PGT123, a broadly reactive and potent HIV-1 neutralizing antibody

4JY6 · PGT123 light chain: “Crystal structure of human Fab PGT123, a broadly reactive and potent HIV-1 neutralizing antibody”. X-ray diffraction, 1 ligand (ZN), 12 pockets (best druggability 0.59). MolNFT v1 #96923 on GenesisL1: 3D…

PDB
4JY6
Type
protein
Length
875 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
PGT123 light chain; PGT123 heavy chain
Ligands
ZN
Pockets
12 · best druggability 0.59

Structure

x-ray diffraction · 4 distinct chains · 7% helix, 51% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APGT123 light chainprotein2086% helix, 49% strand—
BPGT123 heavy chainprotein2308% helix, 53% strand—
CPGT123 light chainprotein2066% helix, 49% strand—
DPGT123 heavy chainprotein2319% helix, 52% strand—

Ligands and binding sites

  • ZN · Zinc ion · metal · 18 copies · chains A, B, C, D
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

12 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13990.590.7640empty
23890.580.7545empty
33220.540.7534empty
4500.480.8615empty
5630.400.8017empty

Interfaces

3 interfaces between chains.

  • A–B · 2027 Ų buried · 13 hydrogen bonds · protein-protein
  • C–D · 2005 Ų buried · 14 hydrogen bonds · protein-protein
  • B–D · 239 Ų buried · 2 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 8 disulfide (disulfide).

Compared structures

  • 4JY6 · Crystal structure of human Fab PGT123, a broadly reactive and potent HIV-1 neutralizing… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.